NRSN
NeuroSense Therapeutics Ltd.
Company overview
- Market capitalization
- —
- Employees
- 17
- Latest publication
- 2026-09-29
About NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.
Financial statements
Income Quarterly
| Metric | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 1,862,000USD | 1,862,000USD | 1,251,500USD | 1,251,500USD | 1,086,000USD | 1,161,000USD | 1,569,000USD | 1,882,000USD |
| Selling General Administrative | 1,334,500USD | 1,334,500USD | 1,094,500USD | 1,094,500USD | 685,000USD | 946,000USD | 1,461,000USD | 1,112,000USD |
| Total Operating Expenses | 3,196,500USD | 3,196,500USD | 2,346,000USD | 2,346,000USD | 1,771,000USD | 2,107,000USD | 3,030,000USD | 2,994,000USD |
| Operating Income | -3,196,500USD | -3,196,500USD | -2,346,000USD | -2,346,000USD | -1,771,000USD | -2,107,000USD | -3,030,000USD | -2,994,000USD |
| Income Before Tax | -3,208,000USD | -3,208,000USD | -2,354,500USD | -2,354,500USD | -1,801,000USD | -2,148,000USD | -857,000USD | -5,404,000USD |
| Net Income | -3,208,000USD | -3,208,000USD | -2,354,500USD | -2,354,500USD | -1,801,000USD | -2,148,000USD | -857,000USD | -5,404,000USD |
| Ebit | -3,196,500USD | -3,196,500USD | -2,346,000USD | -2,346,000USD | -1,771,000USD | -2,107,000USD | -857,000USD | -2,994,000USD |
| Ebitda | -3,192,500USD | -3,192,500USD | -2,342,000USD | -2,342,000USD | — | -2,101,750USD | -851,500USD | -2,988,750USD |
| Depreciation And Amortization | 4,000USD | 4,000USD | 4,000USD | 4,000USD | — | 5,250USD | 5,500USD | 5,250USD |
| Total Other Income Expense Net | -11,500USD | -11,500USD | -8,500USD | -8,500USD | — | -41,000USD | 2,173,000USD | -2,410,000USD |
| Interest Expense | — | — | 8,500USD | 8,500USD | — | 41,000USD | 2,173,000USD | 2,410,000USD |
| Total Revenue | — | — | — | — | 0USD | 0USD | 0USD | 0USD |
| Net Interest Income | — | — | — | — | -31,000USD | -41,000USD | 2,173,000USD | -2,410,000USD |
| Net Income From Continuing Ops | — | — | — | — | -1,801,000USD | -2,148,000USD | -857,000USD | -5,404,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | -43,276USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 6,227,000USD | 5,698,000USD | 7,274,000USD | 2,495,000USD | 898,000USD |
| Selling General Administrative | 4,858,000USD | 4,204,000USD | 4,775,000USD | 393,000USD | 337,000USD |
| Total Operating Expenses | 11,085,000USD | 9,902,000USD | 12,049,000USD | 2,888,000USD | 1,235,000USD |
| Operating Income | -11,085,000USD | -9,902,000USD | -12,049,000USD | -2,888,000USD | -1,235,000USD |
| Interest Income | 13,000USD | 2,000USD | 178,000USD | 61,000USD | 18,000USD |
| Net Interest Income | 7,000USD | -309,000USD | -372,000USD | 60,000USD | 13,000USD |
| Income Before Tax | -11,125,000USD | -10,210,000USD | -10,107,000USD | -2,828,000USD | -1,222,000USD |
| Net Income | -11,125,000USD | -10,210,000USD | -10,107,000USD | -2,828,000USD | -1,227,000USD |
| Net Income From Continuing Ops | -11,125,000USD | -10,210,000USD | -11,280,000USD | -2,828,000USD | -1,222,000USD |
| Ebit | -11,125,000USD | -9,899,000USD | -9,659,000USD | -2,828,000USD | -2,488,000USD |
| Ebitda | -11,109,000USD | -9,877,000USD | -9,638,000USD | -2,825,000USD | -1,253,000USD |
| Depreciation And Amortization | 16,000USD | 22,000USD | 21,000USD | 3,000USD | 1,235,000USD |
| Reconciled Depreciation | 16,000USD | 22,000USD | 97,000USD | 3,000USD | 0USD |
| Total Other Income Expense Net | -40,000USD | -308,000USD | 1,942,000USD | 60,000USD | 13,000USD |
| Cost Of Revenue | — | 22,000USD | 97,000USD | 3,000USD | — |
| Gross Profit | — | -22,000USD | -97,000USD | -3,000USD | — |
| Interest Expense | — | 311,000USD | 550,000USD | 1,000USD | 5,000USD |
| Income Tax Expense | — | — | -1USD | 1,000USD | 5,000USD |
| Net Income Applicable To Common Shares | — | — | — | -2,828,000USD | -1,222,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,028,000USD | 1,028,000USD | 1,684,000USD | 1,684,000USD | 4,575,000USD | 984,000USD | 1,841,000USD | 1,446,000USD |
| Other Current Assets | 579,000USD | 160,000USD | 43,000USD | 890,000USD | — | 35,000USD | 35,000USD | 36,000USD |
| Total Liab | 2,588,000USD | 2,588,000USD | 2,203,000USD | 2,203,000USD | 1,992,000USD | 3,802,000USD | 3,544,000USD | 8,439,000USD |
| Total Stockholder Equity | -1,560,000USD | -1,560,000USD | -519,000USD | -519,000USD | 2,583,000USD | -2,818,000USD | -1,703,000USD | -6,993,000USD |
| Other Current Liab | 1,619,000USD | 1,619,000USD | 1,110,000USD | 1,110,000USD | — | 2,391,000USD | 2,025,000USD | 2,151,000USD |
| Capital Stock | 0USD | — | 0USD | — | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -47,785,000USD | -47,785,000USD | -41,369,000USD | -41,369,000USD | -36,660,000USD | -34,530,000USD | -32,382,000USD | -31,525,000USD |
| Cash | 166,000USD | 166,000USD | 666,000USD | 666,000USD | 3,378,000USD | 344,000USD | 1,208,000USD | 735,000USD |
| Cash And Short Term Investments | 166,000USD | 166,000USD | 666,000USD | 666,000USD | — | 344,000USD | 1,243,000USD | 735,000USD |
| Total Current Assets | 778,000USD | 778,000USD | 1,556,000USD | 1,556,000USD | 4,402,000USD | 785,000USD | 1,619,000USD | 1,192,000USD |
| Total Current Liabilities | 2,516,000USD | 2,516,000USD | 2,203,000USD | 2,203,000USD | 1,992,000USD | 3,783,000USD | 3,508,000USD | 4,535,000USD |
| Net Debt | 4,000USD | 4,000USD | -666,000USD | -666,000USD | — | -325,000USD | -1,172,000USD | -680,000USD |
| Short Term Debt | 98,000USD | 98,000USD | — | 73,000USD | — | — | — | 69,000USD |
| Short Long Term Debt Total | 170,000USD | 170,000USD | — | 73,000USD | — | 19,000USD | 36,000USD | 55,000USD |
| Net Receivables | 33,000USD | — | 847,000USD | 164,000USD | — | 406,000USD | 376,000USD | 421,000USD |
| Accounts Payable | 799,000USD | 799,000USD | 1,093,000USD | 1,093,000USD | 1,160,000USD | 1,392,000USD | 1,483,000USD | 2,384,000USD |
| Property Plant Equipment Net | 228,000USD | 228,000USD | 105,000USD | 105,000USD | 150,000USD | 176,000USD | 200,000USD | 231,000USD |
| Property Plant Equipment Gross | 304,000USD | — | 105,000USD | — | 210,000USD | 176,000USD | 200,000USD | 231,000USD |
| Common Stock Shares Outstanding | 25,560,037shares | 25,560,037shares | 25,402,649shares | 25,402,649shares | 23,228,941shares | 19,809,000shares | 18,055,000shares | 15,405,000shares |
| Non Current Assets Total | 250,000USD | 250,000USD | 128,000USD | 128,000USD | 173,000USD | 199,000USD | 222,000USD | 254,000USD |
| Non Current Liabilities Total | 72,000USD | 72,000USD | 0USD | — | 0USD | 19,000USD | 36,000USD | 3,904,000USD |
| Non Currrent Assets Other | 22,000USD | 22,000USD | 23,000USD | 23,000USD | 23,000USD | 23,000USD | 22,000USD | 23,000USD |
| Net Working Capital | -1,738,000USD | — | -647,000USD | — | 2,410,000USD | -2,998,000USD | -1,889,000USD | -3,343,000USD |
| Unclassified Equity | 46,225,000USD | 46,225,000USD | 40,850,000USD | 40,850,000USD | 39,243,000USD | 31,712,000USD | — | — |
| Inventory | — | 452,000USD | — | — | — | — | — | -457,000USD |
| Unclassified Current Assets | — | — | — | — | 1,024,000USD | — | — | — |
| Short Term Investments | — | — | — | — | — | — | 35,000USD | — |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | 30,679,000USD | 24,532,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | — | 3,904,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 1,028,000USD | 4,575,000USD | 3,185,000USD | 7,710,000USD | 11,431,000USD | 779,000USD | 955,000USD |
| Other Current Assets | 579,000USD | 860,000USD | 110,000USD | 160,000USD | 349,000USD | 67USD | 18USD |
| Total Liab | 2,588,000USD | 1,992,000USD | 4,944,000USD | 2,091,000USD | 2,425,000USD | 120,000USD | 37,000USD |
| Total Stockholder Equity | -1,560,000USD | 2,583,000USD | -1,759,000USD | 5,619,000USD | 9,006,000USD | 659,000USD | 918,000USD |
| Other Current Liab | 1,619,000USD | 759,000USD | 1,931,000USD | 1,164,000USD | 558,000USD | 65,000USD | 14,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -47,785,000USD | -36,660,000USD | -26,121,000USD | -20,786,000USD | -8,446,000USD | -4,405,000USD | -1,577,000USD |
| Cash | 166,000USD | 3,378,000USD | 2,640,000USD | 3,543,000USD | 11,063,000USD | 699,000USD | 895,000USD |
| Cash And Short Term Investments | 166,000USD | 3,378,000USD | 2,640,000USD | 7,090,000USD | 11,063,000USD | 699,000USD | 895,000USD |
| Total Current Assets | 778,000USD | 4,402,000USD | 2,916,000USD | 7,381,000USD | 11,412,000USD | 729,000USD | 913,000USD |
| Total Current Liabilities | 2,516,000USD | 1,992,000USD | 3,459,000USD | 1,726,000USD | 597,000USD | 120,000USD | 37,000USD |
| Net Debt | 4,000USD | -3,305,000USD | -2,498,000USD | -3,332,000USD | -9,235,000USD | -699,000USD | -895,000USD |
| Short Term Debt | 98,000USD | 73,000USD | 69,000USD | 64,000USD | — | — | — |
| Short Long Term Debt Total | 170,000USD | 73,000USD | 142,000USD | 211,000USD | 1,828,000USD | — | — |
| Net Receivables | 33,000USD | 164,000USD | 166,000USD | 131,000USD | 178,000USD | 30,000USD | 18,000USD |
| Accounts Payable | 799,000USD | 1,160,000USD | 1,459,000USD | 498,000USD | 39,000USD | 55,000USD | 23,000USD |
| Property Plant Equipment Net | 228,000USD | 150,000USD | 247,000USD | 306,000USD | 19,000USD | 13,000USD | 7,000USD |
| Property Plant Equipment Gross | 304,000USD | 210,000USD | 276,000USD | 323,000USD | 24,000USD | 16,000USD | 7,000USD |
| Common Stock Shares Outstanding | 25,481,343shares | 18,602,000shares | 13,640,000shares | 11,505,000shares | 10,856,000shares | 5,519,000shares | 5,454,000shares |
| Non Current Assets Total | 250,000USD | 173,000USD | 269,000USD | 329,000USD | 19,000USD | 50,000USD | 42,000USD |
| Non Current Liabilities Total | 72,000USD | 0USD | 1,485,000USD | 365,000USD | 1,828,000USD | 55,000USD | 23,000USD |
| Non Currrent Assets Other | 22,000USD | 23,000USD | 22,000USD | 23,000USD | — | 37,000USD | 35,000USD |
| Net Working Capital | -1,738,000USD | 2,410,000USD | -543,000USD | 5,655,000USD | 10,815,000USD | 609,000USD | 876,000USD |
| Unclassified Equity | 46,225,000USD | 39,243,000USD | — | — | — | — | — |
| Other Assets | — | — | -9,000USD | — | 0USD | 37,000USD | 0USD |
| Short Term Investments | — | — | 0USD | 3,547,000USD | 0USD | — | — |
| Accumulated Other Comprehensive Income | — | — | 24,362,000USD | 26,405,000USD | 17,452,000USD | 5,063,000USD | 2,494,000USD |
| Unclassified Non Current Liabilities | — | — | 1,485,000USD | — | — | — | — |
| Inventory | — | — | — | -3,678,000USD | -178,000USD | -67USD | -18USD |
| Other Liab | — | — | — | — | 1,828,000USD | — | — |
| Net Tangible Assets | — | — | — | — | 9,006,000USD | 659,000USD | 918,000USD |
| Common Stock | — | — | — | — | — | 1,000USD | 1,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q4 20242024-12-31 · USD | Q2 20242024-06-30 · USD | Q4 20232023-12-31 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD | Q2 20222022-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,208,000USD | -3,208,000USD | -1,801,000USD | -857USD | -2,950,000USD | 784USD | -5,225USD | -3,481,000USD |
| Depreciation | 4,000USD | 4,000USD | — | — | — | — | — | — |
| Stock Based Compensation | 917,000USD | 917,000USD | — | 306USD | — | -1,784USD | 1,784USD | — |
| Other Non Cash Items | -170,000USD | -170,000USD | — | 551USD | — | 1,000USD | 3,441USD | — |
| Change To Account Receivables | -70,500USD | -70,500USD | — | — | — | — | — | — |
| Change In Working Capital | 621,500USD | 621,500USD | — | — | — | — | — | 0USD |
| Total Cash From Operating Activities | -1,835,500USD | -1,835,500USD | — | — | — | — | 1,784USD | — |
| Capital Expenditures | -1,500USD | -1,500USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -1,837,000USD | -1,837,000USD | — | — | — | — | 1,784USD | — |
| Total Cashflows From Investing Activities | 2,500USD | 2,500USD | — | — | — | — | — | — |
| Total Cash From Financing Activities | 1,565,500USD | 1,565,500USD | — | — | — | — | — | — |
| Other Cashflows From Investing Activities | 4,000USD | 4,000USD | — | — | — | — | — | — |
| Other Cashflows From Financing Activities | 1,565,500USD | 1,565,500USD | — | — | — | — | — | — |
| Begin Period Cash Flow | — | — | — | 2,640,000USD | 4,796,000USD | 7,127,000USD | 1,398,000USD | — |
| End Period Cash Flow | — | — | — | — | 4,796,000USD | 4,796,000USD | 7,127,000USD | 4,372,000USD |
| Change In Cash | — | — | — | — | — | -2,331,000USD | 5,729,000USD | — |
| Change To Liabilities | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|---|---|
| Net Income | -11,125,000USD | -10,210,000USD | -10,107,000USD | -12,340,000USD | -4,041,000USD | -2,828,000USD | -1,222,000USD |
| Depreciation | 16,000USD | 22,000USD | 21,000USD | 89,000USD | 3,000USD | 3,000USD | 3,000USD |
| Stock Based Compensation | 2,140,000USD | 557,000USD | 1,537,000USD | 5,105,000USD | 4,159,000USD | 2,061,000USD | 611,000USD |
| Other Non Cash Items | -46,000USD | 277,000USD | -1,713,000USD | -1,190,000USD | 791,000USD | -2,000USD | 591,000USD |
| Change In Working Capital | 1,344,000USD | -781,000USD | 1,908,000USD | 750,000USD | 273,000USD | 71,000USD | 29,000USD |
| Total Cash From Operating Activities | -7,671,000USD | -10,135,000USD | -8,354,000USD | -7,586,000USD | -1,539,000USD | -695,000USD | -582,000USD |
| Capital Expenditures | -8,000USD | -3,000USD | -29,000USD | -70,000USD | -17,000USD | -9,000USD | -7,000USD |
| Free Cash Flow | -7,679,000USD | -10,138,000USD | -8,383,000USD | -7,656,000USD | -1,556,000USD | -704,000USD | -589,000USD |
| Investments | 0USD | 1,000USD | 3,646,000USD | -3,541,000USD | -17,000USD | -9,000USD | -26,000USD |
| Total Cashflows From Investing Activities | -8,000USD | 1,000USD | 3,468,000USD | -3,541,000USD | -17,000USD | -9,000USD | -26,000USD |
| Total Cash From Financing Activities | 4,432,000USD | 10,913,000USD | 3,975,000USD | 3,695,000USD | 11,902,000USD | 508,000USD | 1,417,000USD |
| Issuance Of Capital Stock | 4,531,000USD | 11,304,000USD | 3,970,000USD | 0USD | 9,864,000USD | 508,000USD | 1,420,000USD |
| Change In Cash | -3,212,000USD | 738,000USD | -903,000USD | -7,520,000USD | 10,364,000USD | -196,000USD | 809,000USD |
| Begin Period Cash Flow | 3,378,000USD | 2,640,000USD | 3,543,000USD | 11,063,000USD | 699,000USD | 895,000USD | 86,000USD |
| End Period Cash Flow | 166,000USD | 3,378,000USD | 2,640,000USD | 3,543,000USD | 11,063,000USD | 699,000USD | 895,000USD |
| Other Cashflows From Financing Activities | -121,000USD | -391,000USD | 85,000USD | -96,000USD | 800,000USD | -9,000USD | -3,000USD |
| Other Cashflows From Investing Activities | — | 4,000USD | -6,000USD | 29,000USD | — | — | -19,000USD |
| Change To Account Receivables | — | — | 19,000USD | 55,000USD | -204,000USD | -12,000USD | -3,000USD |
| Net Borrowings | — | — | -80,000USD | -79,000USD | 0USD | — | -3,000USD |
| Change To Inventory | — | — | — | -55,000USD | 204,000USD | 12,000USD | 3,000USD |
| Unclassified Financing Cash Flow | — | — | — | 3,870,000USD | 1,238,000USD | — | — |
| Change To Liabilities | — | — | — | — | -16,000USD | 32,000USD | 23,000USD |
| Unclassified Operating Cash Flow | — | — | — | — | -2,724,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.